4-butyrolactone has been researched along with Koch's Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Hammoud, S; Kremer, L; Maaliki, C; Raynaud, C; Thibonnet, J; Thiery, E; Viljoen, A; Villaume, S; Vincent, SP | 1 |
| Chras, G; Constantoulakis, P; Filiou, E; Hamhougia, A; Karabela, S; Poulakis, N; Roussos, C; Rovina, N; Sotiriou, A | 1 |
2 other study(ies) available for 4-butyrolactone and Koch's Disease
| Article | Year |
|---|---|
Synthesis and evaluation of heterocycle structures as potential inhibitors of Mycobacterium tuberculosis UGM.
Topics: 4-Butyrolactone; Antitubercular Agents; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Indoles; Intramolecular Transferases; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Protein Binding; Tuberculosis | 2020 |
In vivo expression of innate immunity markers in patients with Mycobacterium tuberculosis infection.
Topics: 4-Butyrolactone; Adult; Blood; Cells, Cultured; Female; Gene Expression Profiling; Humans; Immunity, Innate; Male; Middle Aged; Minor Histocompatibility Antigens; Mycobacterium tuberculosis; Nuclear Proteins; RNA, Messenger; Toll-Like Receptors; Tuberculosis; Up-Regulation | 2010 |